UPDATES IN MANAGEMENT OF DESIGNER

ABSTRACTThe designer drug is a drug with properties and effects similar to a known hallucinogen.The use of the designer drugs has increased significantly over the past 2 decades, especially among young teens between the ages of 16 to 30.Observations suggest that genetic and environmental conditions that differentially predispose individuals to drug-taking behavior and maintained drug abuse.There is a biological basis for drug addiction. Recreational drug use causes the release and prolonged action of dopamine and serotonin within the reward circuitThe designer drugs are classified to stimulant drugs such as MDMA, methamphetamine, ketamine and hallucinogenic (LSD, 2-CB) and depressant drugs such as GHB and rohypnol.Gas chromatography / mass spectrometry (GC / MS) is the procedure generally accepted for the confirmed identification of drugs of abuse.Effective treatment attends to multiple needs of the individual, not just his or her drug use.The best programs provide a combination of therapies and other services to meet the needs of the individual patient.Medications are an important element of treatment for many patients, especially when combined with counseling and other behavioral therapies.There are no specific antidotes for ingestion of designer drugs except for rohypnol, which has the antidote flumazenil.